Insilico Medicine
Hong Kong, US · Founded 2019 · 291 employees on LinkedIn · 20 known investors
Find your way into Insilico Medicine
Each arrow is one introduction. Sign up to fill in the first one.
Ask Krish Ramadurai to introduce you to Feng Ren
You →Krish · together at Insilico Medicine →Feng
Ask Jamie Chen to introduce you to Alex Zhavoronkov
You →Jamie · together at Deep Longevity →Alex
Sign up to find every way you can get introduced to Insilico Medicine
- Your email: who you already know at Insilico Medicine, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Insilico Medicine team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development. It collaborates with global biopharma companies and academic institutions on drug discovery projects.
Founders & leadership
Insilico Medicine was founded in 2019 by Aleksandrs Zavoronkovs, Alex Zavoronkov, Alex Zhavoronkov, and Alex Aliper.


Board

Investors · 20
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
How we know: OrbiMed's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: Qiming Venture Partners's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: Warburg Pincus's portfolio page · the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: B Capital Group's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Bold Capital Partners's portfolio page · Not right? Tell us
How we know: BOLD Longevity's portfolio page · Not right? Tell us
How we know: F-Prime Capital's portfolio page · Not right? Tell us
How we know: Harmonix Fund's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$49.5M disclosed across 4 rounds · 2016–2019
▶$36.8MraisedSep 2019 · 21 investors · BiotechnologyRule 506(b)
- [none] WNL LimitedDirector
- Nisa LeungDirector
- Lennart LeeDirector
- Alex ZavoronkovDirector
- James MellonDirector
- Offering amount
- $36.8M
- Amount sold
- $36.8M
- First sale
- Sep 2019
- Incorporated
- Other, Cayman Islands, 2019
- Federal exemptions
- 06b
▶$6MraisedJun 2018 · 15 investors · BiotechnologyRule 506(b)
- Alex ZhavoronkovExecutive Officer, Director
- James MellonDirector
- Qingsong ZhuExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4MraisedJul 2017 · 1 investors · BiotechnologyRule 506(b)
- Aleksandrs ZavoronkovsExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $4M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.8MraisedJul 2017 · 17 investors · BiotechnologyRule 506(b)
- Aleksandrs ZavoronkovsExecutive Officer, Director
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Minimum investment
- $25K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Insilico Medicine went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Insilico Medicine.
In the news
Frequently asked questions
- What does Insilico Medicine do?
- Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development. It collaborates with global biopharma companies and academic institutions on drug discovery projects.
- Who founded Insilico Medicine?
- Insilico Medicine was founded by Aleksandrs Zavoronkovs, Alex Zavoronkov, Alex Zhavoronkov, Alex Aliper in 2019.
- Who are Insilico Medicine's investors?
- Insilico Medicine's investors include Lilly Asia Ventures, OrbiMed, Qiming Venture Partners, Warburg Pincus, Baidu Ventures, Eight Roads Ventures, Lake Bleu Capital, Sinovation Ventures and 12 more.
- How much funding has Insilico Medicine raised?
- Insilico Medicine has disclosed $49.5M raised across 4 rounds.
- Where is Insilico Medicine headquartered?
- Insilico Medicine is headquartered in Hong Kong, US.










.jpeg)






